Antimicrobial resistance is one of the world’s leading health threats, yet little is being done. But it doesn’t have to be this way.
Imagine a world where even the most routine operations become life threatening and treatments for diseases such as cancer are just too dangerous to administer. After decades of medical progress, it may seem far-fetched, but the emergence of antimicrobial resistance (AMR) makes this a very real and present danger.
COVID-19 has pushed health systems to their limits. Now is the time to build on the lessons learned from this crisis to #PowerUpHealth. Discover howhere.
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.